KL0011034 injection

DRUG4 trials

Sponsors

Hunan Kelun Pharmaceutical Co., Ltd., The Third Xiangya Hospital of Central South University

Conditions

Chronic PainHealthy Volunteers

Phase 1

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers

RecruitingNCT07474545

Hunan Kelun Pharmaceutical Co., Ltd.Healthy Volunteers

Start: 2026-03-02End: 2027-12-31Target: 76Updated: 2026-05-27

A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection

CompletedNCT07710560

Hunan Kelun Pharmaceutical Co., Ltd.Chronic Pain

Start: 2026-07-15End: 2026-08-12Updated: 2026-09-17

A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain

Not yet recruitingNCT07751094

The Third Xiangya Hospital of Central South UniversityChronic Pain

Start: 2026-07-30End: 2027-07-31Target: 27Updated: 2026-08-07

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects

Not yet recruitingNCT07828470

Hunan Kelun Pharmaceutical Co., Ltd.Healthy Volunteers

Start: 2026-10-13End: 2026-11-13Target: 30Updated: 2026-09-18